Vor Biopharma Inc (NASDAQ: VOR) on Friday, plunged -11.01% from the previous trading day, before settling in for the closing price of $13.08. Within the past 52 weeks, VOR’s price has moved between $2.62 and $65.80.
During the last 5-year period, the sales drop of Healthcare Sector giant was -38.02%. The company achieved an average annual earnings per share of -233.86%. With a float of $17.36 million, this company’s outstanding shares have now reached $21.91 million.
Vor Biopharma Inc (VOR) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Vor Biopharma Inc is 36.70%, while institutional ownership is 42.16%. The most recent insider transaction that took place on Oct 29 ’25, was worth 6,343,284. In this transaction Director of this company sold 251,518 shares at a rate of $25.22, taking the stock ownership to the 804,231 shares. Before that another transaction happened on Oct 28 ’25, when Company’s Director sold 124,311 for $27.42, making the entire transaction worth $3,408,230. This insider now owns 1,055,749 shares in total.
Vor Biopharma Inc (VOR) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -8.8 earnings per share (EPS) for the period falling under the consensus outlook (set at -6.13) by -2.67. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.56 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -233.86% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.54% during the next five years compared to -38.02% drop over the previous five years of trading.
Vor Biopharma Inc (NASDAQ: VOR) Trading Performance Indicators
Vor Biopharma Inc (VOR) is currently performing well based on its current performance indicators. A quick ratio of 9.16 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -386.85, a number that is poised to hit -1.00 in the next quarter and is forecasted to reach -5.81 in one year’s time.
Technical Analysis of Vor Biopharma Inc (VOR)
As of the previous 9 days, the stock’s Stochastic %D was 21.42%.
During the past 100 days, Vor Biopharma Inc’s (VOR) raw stochastic average was set at 11.76%, which indicates a significant increase from 0.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.76 in the past 14 days, which was lower than the 2.54 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $14.31, while its 200-day Moving Average is $22.36. However, in the short run, Vor Biopharma Inc’s stock first resistance to watch stands at $12.95. Second resistance stands at $14.25. The third major resistance level sits at $14.91. If the price goes on to break the first support level at $10.98, it is likely to go to the next support level at $10.32. Now, if the price goes above the second support level, the third support stands at $9.02.
Vor Biopharma Inc (NASDAQ: VOR) Key Stats
Market capitalization of the company is 255.04 million based on 10,411K outstanding shares. Right now, sales total 0 K and income totals -116,914 K. The company made 0 K in profit during its latest quarter, and -812,684 K in sales during its previous quarter.
